The search result changed since you submitted your search request. Documents might be displayed in a different sort order.
  • search hit 9 of 9
Back to Result List

Plant-Based Production of Recombinant Plasmodium Surface Protein Pf38 and Evaluation of its Potential as a Vaccine Candidate

Please always quote using this URN: urn:nbn:de:bvb:20-opus-128221
  • Pf38 is a surface protein of the malarial parasite Plasmodium falciparum. In this study, we produced and purified recombinant Pf38 and a fusion protein composed of red fluorescent protein and Pf38 (RFP-Pf38) using a transient expression system in the plant Nicotiana benthamiana. To our knowledge, this is the first description of the production of recombinant Pf38. To verify the quality of the recombinant Pf38, plasma from semi-immune African donors was used to confirm specific binding to Pf38. ELISA measurements revealed that immune responsesPf38 is a surface protein of the malarial parasite Plasmodium falciparum. In this study, we produced and purified recombinant Pf38 and a fusion protein composed of red fluorescent protein and Pf38 (RFP-Pf38) using a transient expression system in the plant Nicotiana benthamiana. To our knowledge, this is the first description of the production of recombinant Pf38. To verify the quality of the recombinant Pf38, plasma from semi-immune African donors was used to confirm specific binding to Pf38. ELISA measurements revealed that immune responses to Pf38 in this African subset were comparable to reactivities to AMA-1 and \(MSP1_{19}\). Pf38 and RFP-Pf38 were successfully used to immunise mice, although titres from these mice were low (on average 1:11.000 and 1:39.000, respectively). In immune fluorescence assays, the purified IgG fraction from the sera of immunised mice recognised Pf38 on the surface of schizonts, gametocytes, macrogametes and zygotes, but not sporozoites. Growth inhibition assays using \(\alpha Pf38\) antibodies demonstrated strong inhibition \((\geq 60 \% ) \) of the growth of blood-stage P. falciparum. The development of zygotes was also effectively inhibited by \(\alpha Pf38\) antibodies, as determined by the zygote development assay. Collectively, these results suggest that Pf38 is an interesting candidate for the development of a malaria vaccine.show moreshow less

Download full text files

Export metadata

Additional Services

Share in Twitter Search Google Scholar Statistics
Metadaten
Author: Tatjana Feller, Pascal Thom, Natalie Koch, Holger Spiegel, Otchere Addai-Mensah, Rainer Fischer, Andreas Reimann, Gabriele Pradel, Rolf Fendel, Stefan Schillberg, Matthias Scheuermayer, Helga Schinkel
URN:urn:nbn:de:bvb:20-opus-128221
Document Type:Journal article
Faculties:Medizinische Fakultät / Institut für Molekulare Infektionsbiologie
Language:English
Parent Title (English):PLOS ONE
ISSN:1932-6203
Year of Completion:2013
Volume:8
Issue:11
Pagenumber:e79920
Source:PLoS ONE 8(11): e79920. doi:10.1371/journal.pone.0079920
DOI:https://doi.org/10.1371/journal.pone.0079920
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 615 Pharmakologie, Therapeutik
Tag:N-glycans; antibodies; antigen; balancing selection; expression; falciparum; identification; malaria vaccine; tobacco; transmission
Release Date:2016/03/30
Licence (German):License LogoCC BY: Creative-Commons-Lizenz: Namensnennung